Reshmi I Srinath, MD

Reshmi Srinath, MD, is an Associate Professor of Medicine in the Division of Endocrinology, Diabetes and Bone Disease; and is Director of the Mount Sinai Weight and Metabolism Management Program.
She is dually certified in endocrinology and obesity medicine (American Board of Obesity Medicine).
Her interests in metabolism, nutrition and prevention of metabolic disease began while she was in college as a Division 1 tennis player. which led her to pursue a career in medicine specializing in endocrinology.
Dr. Srinath graduated from the University of Connecticut School of Medicine with a merit scholarship, before completing her residency in internal medicine at Duke University Hospital in Durham, North Carolina. She went on to pursue fellowship training in endocrinology at Johns Hopkins University in Baltimore, Maryland, before coming to Mount Sinai. 


      

As a faculty member at the Icahn School of Medicine at Mount Sinai, she is an expert in the assessment, treatment, and prevention of obesity, type 2 diabetes and other metabolic complications of weight. She is also involved in supervising students, residents and fellows both inpatient and in various clinics. She co-authored the 2025 AACE Algorithm for the Evaluation and Treatment of Adults with Obesity/ABCD, and currently serves on the Endocrine Society Steering committee for the ESAP-In Training Exam for Fellows and on the Item-writing committee for the ABOM Obesity certification exam. 

Dr. Srinath’s research includes industry-funded studies examining the role of continuous glucose monitoring in patients with obesity, as well as a collaborative project evaluating duodenal mucosal resurfacing for type 2 diabetes. She is also involved in post-hoc analyses of tirzepatide in clinical trials.

She has been published in The New York Times, US News and World Report, New York Magazine, the Cut, CBS News Sunday Morning, PIX11 News, and in Our Town Newspaper.

Dr. Srinath is dedicated to providing exceptional care to patients with obesity, diabetes and metabolic disease, while expanding on her research in these areas.